Novartis Group

Rediff.com » News » Novartis Group

News for Novartis Group

News
Business

India's New Trilemma

...Kids, jobs, emigration, notes Ajit Balakrishnan. Illustration: Dominic Xavier/Rediff.com "Aren't you kids going to have children?" I asked one of my nieces who had come for a one-week......

Covid Vaccine IP: How Big Pharma lobbied against India

Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual......

'Swine flu spreading through locals, among locals'

"There is no panic about the swine flu in Gujarat. We have assured quick diagnosis and quicker treatment up to the district level. We are taking the pandemic very seriously. So far, of all the......

Studying at ISB to cost over Rs 20 lakh

The Indian School of Business, ranked in the top 12 global B-schools by the Financial Times, has increased its tuition fee to Rs 15.3 lakh (Rs 1.53 million) per annum -- Rs 80,000 more than Rs 14.5......

Abbott Labs sues Ranbaxy

Abbott Laboratories is suing India's Ranbaxy Laboratories as well as Israel's Teva and Sandoz of the Novartis group, in Chicago for allegedly violating its patents protecting Omnicef, a drug used......

Sandoz in local outsourcing plan

Sandoz, a Novartis group company, is evaluating manufacturing and outsourcing activities in India to optimise capabilities for its global market requirements. Andreas Rummelt, chief executive......

Novartis ruling to impact innovation: US biz groups

Business groups in the US have sharply criticised the Supreme Court of India judgment against Swiss drugmaker Novartis in denying patent protection to the company’s anti-cancer drug......

After 15 years, Ranjit Shahani steps down as Novartis' India chief

The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in......

Rediff News

Novartis Group

News for Novartis Group

India's New Trilemma

Covid Vaccine IP: How Big Pharma lobbied against India

'Swine flu spreading through locals, among locals'

Studying at ISB to cost over Rs 20 lakh

Abbott Labs sues Ranbaxy

Sandoz in local outsourcing plan

Novartis ruling to impact innovation: US biz groups

After 15 years, Ranjit Shahani steps down as Novartis' India chief

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS